Literature DB >> 27213918

Cullin 3 targets methionine adenosyltransferase IIα for ubiquitylation-mediated degradation and regulates colorectal cancer cell proliferation.

Jian Wang1, Zi-Hua Zhu2, Hong-Bin Yang1, Ye Zhang1, Xiang-Ning Zhao1, Min Zhang1, Ying-Bin Liu3, Ying-Ying Xu1, Qun-Ying Lei1.   

Abstract

Cullin 3 (CUL3) serves as a scaffold protein and assembles a large number of ubiquitin ligase complexes. It is involved in multiple cellular processes and plays a potential role in tumor development and progression. In this study, we demonstrate that CUL3 targets methionine adenosyltransferase IIα (MAT IIα) and promotes its proteasomal degradation through the ubiquitylation-mediated pathway. MAT IIα is a key enzyme in methionine metabolism and is associated with uncontrolled cell proliferation in cancer. We presently found that CUL3 down-regulation could rescue folate deprivation-induced MAT IIα exhaustion and growth arrest in colorectal cancer (CRC) cells. Further results from human CRC samples display an inverse correlation between CUL3 and MAT IIα protein levels. Our observations reveal a novel role of CUL3 in regulating cell proliferation by controlling the stability of MAT IIα.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  MAT IIα; colorectal cancer; cullin 3; folate; ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 27213918     DOI: 10.1111/febs.13759

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

1.  Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA.

Authors:  Jin-Tao Li; Hai Yang; Ming-Zhu Lei; Wei-Ping Zhu; Ying Su; Kai-Yue Li; Wen-Ying Zhu; Jian Wang; Lei Zhang; Jia Qu; Lei Lv; Hao-Jie Lu; Zheng-Jun Chen; Lu Wang; Miao Yin; Qun-Ying Lei
Journal:  Signal Transduct Target Ther       Date:  2022-06-22

2.  Downregulation of Talin-1 expression associates with increased proliferation and migration of vascular smooth muscle cells in aortic dissection.

Authors:  Xiaolong Wei; Yudong Sun; Yani Wu; Jiang Zhu; Bin Gao; Han Yan; Zhiqing Zhao; Jian Zhou; Zaiping Jing
Journal:  BMC Cardiovasc Disord       Date:  2017-06-20       Impact factor: 2.298

Review 3.  Metabolic recoding of epigenetics in cancer.

Authors:  Yi-Ping Wang; Qun-Ying Lei
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

4.  Ranking Cancer Proteins by Integrating PPI Network and Protein Expression Profiles.

Authors:  Jie Ren; Lulu Shang; Qing Wang; Jing Li
Journal:  Biomed Res Int       Date:  2019-01-06       Impact factor: 3.411

5.  Increased Expression of Cullin 3 in Nasopharyngeal Carcinoma and Knockdown Inhibits Proliferation and Invasion.

Authors:  Ruifang Zeng; Guolin Tan; Wei Li; Yanhong Ma
Journal:  Oncol Res       Date:  2017-04-18       Impact factor: 5.574

Review 6.  Cancer metabolism and dietary interventions.

Authors:  Lin Qian; Fan Zhang; Miao Yin; Qunying Lei
Journal:  Cancer Biol Med       Date:  2021-12-22       Impact factor: 4.248

7.  KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.

Authors:  Man Yang; Ya-Mei Han; Qiang Han; Xue-Zhu Rong; Xiao-Fang Liu; Xu-Yong Ln
Journal:  J Cell Mol Med       Date:  2021-08-28       Impact factor: 5.310

Review 8.  COVID-19 metabolism: Mechanisms and therapeutic targets.

Authors:  Tianshi Wang; Ying Cao; Haiyan Zhang; Zihao Wang; Cheuk Him Man; Yunfan Yang; Lingchao Chen; Shuangnian Xu; Xiaojing Yan; Quan Zheng; Yi-Ping Wang
Journal:  MedComm (2020)       Date:  2022-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.